Zach Scheiner is a Principal on the Investment Team at RA Capital Management. Zach works on both public and private investments and serves as a Board Director for Adagio Medical, Exo Imaging, LENZ Therapeutics, and Nkarta Therapeutics. Zach holds a B.S. in molecular biophysics and biochemistry from Yale University, and a Ph.D. in neurobiology and behavior from the University of Washington. Zach previously worked as a Science Officer at the California Institute for Regenerative Medicine.